Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 417 | 417 | 417 |
Full Text Views | 9 | 9 | 9 |
PDF Downloads | 10 | 10 | 10 |
People living with HIV (PLWH) are known to exhibit more severe or prolonged symptoms of mpox (formerly monkeypox). However, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on PLWH with mpox has not been adequately described. We report a case of mpox in an AIDS patient who had recurrent symptoms due to SARS-CoV-2 infection. The patient presented with a low CD4+ lymphocyte count (CD4 count) without antiretroviral therapy (ART) and suffered from severe mpox. The ART was initiated 17 days after the diagnosis of mpox, and the patient’s skin lesions began crusting after 1 week of ART. However, after a SARS-CoV-2 infection, the mpox flared up again. The patient presented with more severe symptoms than those during the initial bout and with rectal involvement. We speculate that SARS-CoV-2 infection might cause a recrudescence of mpox in AIDS patients, which requires further investigation.
Financial support: Financial support was received from
Disclosure: We declare that the case report was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Current contact information: Yaqing Liu, Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China, and Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China, E-mail: jqxxqs123@163.com. Shi Zou, Shihui Song, and Mingqi Luo, Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China, E-mails: zoushi321@163.com, shsong2013@163.com, and mingqiluo@163.com. Yingcai Wan and Jianbo Wu, Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, China, E-mails: 326389548@qq.com and wurudai@163.com. Wei Guo, Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China, and Department of Pathology, School of Basic Medical Sciences, Wuhan University, Wuhan, China, E-mail: guowei@whu.edu.cn. Ke Liang, Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China, Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China, Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China, and Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China, E-mail: keliang@whu.edu.cn.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 417 | 417 | 417 |
Full Text Views | 9 | 9 | 9 |
PDF Downloads | 10 | 10 | 10 |